Mirum Pharmaceuticals reported notable outperformance on August 7, 2025, and Chris Peetz was confirmed as the chief executive officer.
1 report, 1 independent
Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Mirum Pharmaceuticals reported notable outperformance on August 7, 2025, and Chris Peetz was confirmed as the chief executive officer.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Coverage
Newest first; wire copies grouped- Business WireMirum Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update - Second quarter 2025 total revenue of $128 million - 2025 revenue guidance increased to $490 to $510